Scarica l'app Stockscreener
5.42
10.61%
0.52
Dopo l'orario di chiusura:
5.31
-0.11
-2.03%
Precedente Chiudi:
$4.90
Aprire:
$5.01
Volume 24 ore:
97,258
Relative Volume:
0.12
Capitalizzazione di mercato:
$5.93M
Reddito:
$1.31M
Utile/perdita netta:
$-14.73M
Rapporto P/E:
-0.2713
EPS:
-19.98
Flusso di cassa netto:
$-4.69M
1 W Prestazione:
+46.88%
1M Prestazione:
+45.31%
6M Prestazione:
+8.18%
1 anno Prestazione:
-7.35%
Intervallo 1D:
$4.9101
$5.62
Intervallo di 1 settimana:
$3.58
$5.62
Portata 52W:
$2.11
$21.60
Avalon Globocare Corp Stock (ALBT) Company Profile
Nome
Avalon Globocare Corp
Settore
Industria
Telefono
732-780-4400
Indirizzo
4400 ROUTE 9, FREEHOLD
Confronta ALBT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALBT
Avalon Globocare Corp
|
5.42 | 5.93M | 1.31M | -14.73M | -4.69M | -19.98 |
|
XHG
Xchange Tec Inc Adr
|
0.9161 | 48.82B | 40.28M | -31.64M | -1.36M | 228.95 |
|
CBRE
Cbre Group Inc
|
135.78 | 40.74B | 35.77B | 968.00M | 1.40B | 3.14 |
|
CSGP
Costar Group Inc
|
76.79 | 31.49B | 2.74B | 138.70M | -245.30M | 0.35 |
|
BEKE
Ke Holdings Inc Adr
|
20.90 | 25.02B | 10.78B | 579.98M | 881.47M | 0.493 |
|
JLL
Jones Lang Lasalle Inc
|
262.07 | 12.42B | 22.50B | 478.00M | 411.90M | 9.89 |
Avalon Globocare Corp Borsa (ALBT) Ultime notizie
Avalon GloboCare (NASDAQ: ALBT) Receives Notice of Allowance for Innovative CAR-T and CAR-NK Cell Technology in ChinaFREEHOLD, N.J., February 18, 2025 – Avalon GloboCare Corp. (NASDAQ: ALBT), a leading developer of precision diagnostics a - Defense World
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China - GlobeNewswire
Avalon GloboCare Receives Notice of Allowance for Chimeric Antigen Receptor Cell Technology in China - Marketscreener.com
Avalon GloboCare Secures Patent for CAR-T Technology - TipRanks
Avalon GloboCare secures patent in China for CAR therapy tech - Investing.com
Avalon GloboCare secures patent in China for CAR therapy tech By Investing.com - Investing.com Canada
Revolutionary Cancer Treatment Patent: Avalon's Dual-Target CAR-T Therapy Gets China's Green Light - StockTitan
Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update - Defense World
Head to Head Analysis: Sangamo Therapeutics (NASDAQ:SGMO) versus Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare announces preferred stock exchange and amendment By Investing.com - Investing.com Australia
Avalon GloboCare announces preferred stock exchange and amendment - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific and Clinical Advisory Board - Marketscreener.com
Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Increase in Short Interest - Defense World
Avalon GloboCare Enters into Securities Purchase Agreement with InvestorOn December 19, 2024, Avalon GloboCare Corp. (NASDAQ: ALBT) announced that it had entered into a securities purchase agreement with an accredited investor, York Sun Investme - Defense World
Avalon GloboCare announces $7M preferred stock sale By Investing.com - Investing.com Nigeria
Avalon GloboCare announces $7M preferred stock sale - Investing.com India
Avalon GloboCare (NASDAQ:ALBT) vs. Krystal Biotech (NASDAQ:KRYS) Head-To-Head Analysis - Defense World
3 Penny Stocks to Watch Now, 12/10/24 - TipRanks
Why Interpublic Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Avalon GloboCare Regains Nasdaq Compliance - Investing.com
Avalon GloboCare Achieves Nasdaq Compliance with Strong Governance - TipRanks
Avalon GloboCare Regains Compliance with Nasdaq Continued Listing Requirements - GlobeNewswire
Avalon GloboCare Regains Nasdaq Compliance, Reaffirms Growth Strategy | ALBT Stock News - StockTitan
Avalon launches ‘BrAce for Impact’ affiliate marketing program - TipRanks
Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device - GlobeNewswire
Avalon GloboCare Launches AI-Powered KetoAir™ Affiliate Program for Ketosis Monitoring | ALBT Stock News - StockTitan
Critical Review: Innate Pharma (NASDAQ:IPHA) vs. Avalon GloboCare (NASDAQ:ALBT) - Defense World
Avalon GloboCare Third Quarter 2024 Earnings: US$1.82 loss per share (vs US$2.06 loss in 3Q 2023) - Yahoo Finance
Avalon GloboCare Corp. (ALBT) Quarterly 10-Q Report - Quartz
U.S. Stock market: Zoomcar Holdings (+192.21%), Avalon GloboCare (+56.73%), and Vimeo (+40.85%) experience significant gains during mid day trading - Business Upturn
U.S. Stock market: Zoomcar Holdings up 87.10%, Avalon GloboCare jumps 57.14%, Vimeo rises 44.07% among top gainers - Business Upturn
U.S. Stock market: Verrica Pharmaceuticals and Marqeta stocks plummet over 37%, while Avalon GloboCare soars 75% in volatile market trend - Business Upturn
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges - Investing.com Canada
Avalon Globocare stock hits 52-week low at $2.4 amid market challenges By Investing.com - Investing.com South Africa
Avalon GloboCare faces Nasdaq delisting after rule breach - Investing.com India
Avalon GloboCare Appoints Dr. Charles Cavo to Scientific Advisory Board Support for KetoAir Sales - Defense World
Avalon GloboCare faces Nasdaq delisting after rule breach By Investing.com - Investing.com South Africa
Avalon appoints Cavto to Scientific Advisory Board - TipRanks
Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales - GlobeNewswire
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares By Investing.com - Investing.com South Africa
Avalon GloboCare Announces Reverse Stock Split and Decrease in Shares - Investing.com
Avalon Globocare stock hits 52-week high at $3.45 By Investing.com - Investing.com South Africa
Avalon Globocare stock hits 52-week high at $3.45 - Investing.com
Avalon Globocare Corp Azioni (ALBT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):